SCAND2P and sarcoma: Moreover, high expression of SCAND2 (and/or lncRNA-SCAND2P) was a predictive biomarker of enhanced prognoses for patients suffering from lung adenocarcinoma, sarcoma, and cervical cancer (Table 7, Figure S6).